Reply To: Website PV updates

Home Forums Pharmacovigilance Forum Website PV updates Reply To: Website PV updates

#39292

Dear PIPA Member

Thank you for your enquiry.

Please note that the response to your query represents the views and suggestions of the PIPA Committee Members and are intended as guidance only. Please refer to the applicable Pharmacovigilance legislation, guidelines and your own company procedures.

The timeline for the upload of PV / Reference Safety Information (RSI) e.g. Summary of Product Characteristics (SmPC) onto a digital platform such as a corporate website is not defined in the UK regulations explicitly.

It is the experience of the PIPA Committee members that such an update is usually made in accordance with internal company procedures and / or at the time an update is provided to the Electronics Medicines Compendium (https://www.medicines.org.uk/emc/about-the-emc#anchor4). The expectation of the emc is as follows:

“How is the information updated?

When there is new information about a medicine, or when a new medicine is launched, the pharmaceutical company should update emc website within 10 days of the UK or European medicines authority approving the change”.

Secondly, as the Good Pharmacovigilance Practice Guide (MHRA Purple Guide) was published in 2009/2010, PIPA members utilise it in conjunction with the EMA’s GVP Modules, which will remain in force until the MHRA publish a guidance note on the exceptions and modifications in due course. Please refer to: https://www.gov.uk/government/publications/guidance-on-pharmacovigilance-procedures-in-the-event-from-1-january-2021/updated-guidance-on-pharmacovigilance-procedures

We do hope the above answers your queries.

PIPA